市场调查报告书
商品编码
1618254
透析设备:市场洞察·竞争环境·市场预测 (~2030年)Dialysis Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
透析设备市场规模预计将从 2023 年的 710 亿美元成长到 2030 年的 943 亿美元,预测期内复合年增长率为 4.84%。
由于急性肾损伤和败血症的增加、技术进步和产品推出,透析设备市场正在经历显着成长。
透析设备:市场动态
根据国际肾臟病学会(2021)的数据,全球每年约有1330万例急性肾损伤(AKI)病例,新兴国家的负担往往更大,病例数逐年增加估计为1130万。医疗保健系统在管理肾臟相关疾病方面面临越来越大的压力,特别是新兴国家急性肾损伤 (AKI) 盛行率不断上升,增加了对透析设备的需求。发病率的上升表明需要先进且易于使用的透析解决方案来提供及时的治疗,从而刺激全球市场的成长和透析设备技术的创新。
根据全球败血症联盟最近更新的 2024 年数据,败血症是一场全球健康危机,每年影响近 47 至 5000 万人。透析装置用于治疗败血症,以提供持续的肾臟支持,包括调节液体平衡、清除毒素和支持整体器官功能。
按透析设备市场的产品类型划分,连续性肾臟替代疗法 (CRRT) 设备领域预计将在 2023 年占据主要销售占有率。这是由于 CRRT 设备提供的多项优势。
CRRT 设备为患有急性肾损伤的危重患者提供了多种优势,尤其是在重症监护环境中。 CRRT 装置提供缓慢、连续的过滤过程,更接近地模仿自然肾功能,最大限度地降低与快速液体转移相关的风险。这种温和的方法对血流动力学不稳定的患者有益,并且可以随着时间的推移更好地控制液体的排出和电解质平衡,从而减少併发症的机会。
此外,CRRT 具有高度可自订性,允许医疗保健专业人员根据个别患者的需求调整液体清除率、透析量和溶质清除率等参数,从而使他们能够治疗危重病症,从而提高患者的疗效和安全性。
本报告提供全球透析设备的市场调查,彙整市场概要,市场影响因素及市场机会分析,法律制度,市场规模的转变·预测,各种区分·地区/各主要国家的详细分析,竞争情形,主要企业简介等资讯。
Dialysis Devices Market by Product Type (Hemodialysis Machines, Peritoneal Dialysis Machines, Continuous Renal Replacement Therapy Machines, and Consumables), Mobility (Stationary and Portable), End-User (Hospitals, Dialysis Centers, and Homecare Settings), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing number of acute kidney injuries and the rising product developmental activities across the globe
The dialysis devices market was valued at USD 71.00 billion in 2023, growing at a CAGR of 4.84% during the forecast period from 2024 to 2030 to reach USD 94.30 billion by 2030. The dialysis devices market is experiencing significant growth due to the increasing instances of acute kidney injury and sepsis, coupled with advancements in technology and product launches which are acting as major factors contributing to the overall growth of the dialysis devices market during the forecast period from 2024 to 2030.
Dialysis Devices Market Dynamics:
As per data from the International Society of Nephrology 2021, each year, there are around 13.3 million cases of acute kidney injury (AKI) globally and the burden is more inclined towards emerging countries where the annual incidence is estimated to be 11.3 million. The rising prevalence of acute kidney injury (AKI), especially in emerging countries, is driving the demand for dialysis devices as healthcare systems face mounting pressure to manage kidney-related conditions. This increased incidence underscores the need for advanced, accessible dialysis solutions to provide timely treatment, fueling market growth and innovation in dialysis equipment technology globally.
According to the recently updated data in 2024 from the Global Sepsis Alliance, sepsis is a global health crisis that afflicts almost 47 to 50 million individuals each year. Dialysis devices are employed to manage sepsis to provide continuous renal support, helping regulate fluid balance, remove toxins, and support overall organ function.
In addition to this, the World Sepsis Day was initiated by the Global Sepsis Alliance in 2012. Each year on September 13th, events are held worldwide to raise awareness for sepsis. These events included activities for medical professionals, sports events, photo exhibitions, pink picnics, gala events, dinners, public gatherings such as open houses in hospitals and healthcare facilities, and various online events.
Moreover, in September 2024, Fresenius Medical Care announced that it launched the newest version of its home hemodialysis (HHD) machine, the NxStage Versi HD with GuideMe software.
Therefore, the factors stated above collectively will drive the overall dialysis devices market growth.
However, risks associated with the use of dialysis devices, alteration of electrolyte levels in the blood, and others may prove to be challenging factors for dialysis device market growth.
Dialysis Devices Market Segment Analysis:
Dialysis Devices Market by Product Type (Hemodialysis Machines, Peritoneal Dialysis Machines, Continuous Renal Replacement Therapy Machines and Consumables), Mobility (Stationary and Portable), End-User (Hospitals, Dialysis Centers, and Homecare Settings), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the dialysis devices market, the continuous renal replacement therapy machines category is expected to have a significant revenue share in the year 2023. This can be ascribed to several advantages offered by continuous renal replacement therapy machines.
Continuous renal replacement therapy (CRRT) machines offer several advantages, especially for critically ill patients with acute kidney injury in intensive care settings. CRRT machines provide a slow and continuous filtration process that more closely mimics natural kidney function, minimizing the risks associated with rapid fluid shifts. This gentler approach is beneficial for hemodynamically unstable patients, as it allows for better control of fluid removal and electrolyte balance over extended periods, reducing the likelihood of complications.
Additionally, CRRT is highly customizable, enabling healthcare providers to adjust parameters like fluid removal rate, dialysis dose, and solute clearance according to individual patient needs, which enhances its effectiveness and safety for patients in critical condition.
Therefore, the widespread uses and various features of continuous renal replacement therapy machines enhance performance and usability, solidifying the significant impact on the growth of the overall dialysis devices market during the forecast period from 2024 to 2030.
North America is expected to dominate the overall dialysis devices market:
Among all the regions, North America is expected to dominate the dialysis devices market in the year 2023 and is expected to do the same during the forecast period. This can be attributed to several factors, including the prevalence of end-stage renal disease (ESRD), ongoing product development activities by regulatory authorities, and the availability of prompt and well-established healthcare facilities, supported by the presence of key players in the region that contribute to the growth of the dialysis devices market in the North America region during the forecast period from 2024 to 2030.
According to the US Department of Health and Human Services 2021, end-stage renal disease (ESRD) is a significant public health problem in the United States and a major source of suffering and poor quality of life for those afflicted. Dialysis devices provide continuous renal support, which is particularly beneficial for patients with severe symptoms or complications.
The prompt and well-established healthcare services and infrastructure further contribute to the growth of the regional dialysis devices market growth. The presence of key players such as B. Braun Melsungen AG, Medtronic, and Baxter with their strong distribution networks ensure widespread availability and accessibility of these devices across the region increasing their revenue shares in the market, and supportive reimbursement programs providing immense growth opportunities for the same.
Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North America dialysis devices market.
Dialysis Devices Market key players:
Some of the key market players operating in the dialysis devices market include Fresenius Medical Care, B. Braun Melsungen AG, Nipro Corporation, Dialife SA, Baxter, NIKKISO CO. LTD., Asahi Kasei Medical, NxStage Medical, Inc, Infomed SA, Medtronic, Anjue Medical Equipment Co., Ltd, Dialco Medical Inc, SWS Hemodialysis Care Co.,Ltd, TORAY MEDICAL CO,.LTD, QUANTA Dialysis Technologies., and others.
Recent Developmental Activities in the Dialysis Devices Market:
Key Takeaways from the Dialysis Devices Market Report Study
Target Audience who can be benefited from this Dialysis Devices Market Report Study
Frequently Asked Questions for the Dialysis Devices Market: